CATALYST PHARMACEUTICALS, INC. Business Finance Contracts & Agreements
34 Contracts & Agreements
- Investment Agreements (2 contracts)
- Note Agreements (1)
- Purchase Agreements (6)
- Registration Rights Agreements (1)
- Stock Agreements (12)
- Underwriting Agreements (9)
- Warrant Agreements (3)
- Amendment to the Investment Agreement, dated as of July 18, 2023, between Santhera and the Company (Filed With SEC on July 21, 2023)
- Investment Agreement, dated as of June 19, 2023, by and between Santhera and the Company (certain identified information has been excluded from the exhibit because it both (i) is... (Filed With SEC on June 23, 2023)
- Asset Purchase Agreement by and between Eisai and the Company, dated as of December 17, 2022 (certain identified information has been excluded from the exhibit because it both (i)... (Filed With SEC on December 22, 2022)
- License and Asset Purchase Agreement, dated as of July 11, 2022, by and between Jacobus Pharmaceutical Company, Inc. and the Company (Filed With SEC on July 12, 2022)
- Description of the Companys Capital Stock (Filed With SEC on March 16, 2022)
- Description of the Companys Capital Stock (Filed With SEC on March 15, 2021)
- Description of the Companys Capital Stock (Filed With SEC on March 16, 2020)
- 10,000,000 Shares Catalyst Pharmaceutical Partners, Inc. Common Stock UNDERWRITINGAGREEMENT (Filed With SEC on February 4, 2015)
- 13,023,750 Shares CatalystPharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 3, 2014)
- CATALYST PHARMACEUTICAL PARTNERS, INC. 8,800,000 shares of Common Stock PLACEMENT AGENT AGREEMENT (Filed With SEC on September 5, 2013)
- CONVERTIBLE PROMISSORY NOTE AND NOTE PURCHASE AGREEMENT (Filed With SEC on October 31, 2012)
- CATALYST PHARMACEUTICAL PARTNERS, INC. 4,000,000 shares of Common Stock and Warrants to purchase up to 1,200,000 shares of Common Stock PLACEMENTAGENT AGREEMENT (Filed With SEC on August 28, 2012)
- CATALYST PHARMACEUTICAL PARTNERS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 28, 2012)
- 6,000,000 Shares Warrants to Purchase 6,000,000 Shares Catalyst Pharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 29, 2012)
- CATALYST PHARMACEUTICAL PARTNERS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 4, 2012)
- [ ] Shares Warrants to Purchase [ ] Shares Catalyst Pharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 4, 2012)
- [ ] Shares Catalyst Pharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 25, 2012)
- CATALYST PHARMACEUTICAL PARTNERS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on October 28, 2011)
- CATALYST PHARMACEUTICAL PARTNERS, INC. 3,046,740 shares of Common Stock and Warrants to purchase up to 1,523,370 shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 28, 2011)
- RIGHTS AGREEMENT between CATALYST PHARMACEUTICAL PARTNERS, INC. and CONTINENTAL STOCK TRANSFER AND TRUST COMPANY as Rights Agent Dated as of September 20, 2011 TABLE OF CONTENTS (Filed With SEC on September 23, 2011)
- 2,259,943 Shares CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 8, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 6, 2010)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 6, 2010)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 2, 2009)
- Ex-10.2 Form of Securities Purchase Agreement (Filed With SEC on September 12, 2008)
- EX-10.3 Stock Option Agreement (Filed With SEC on December 15, 2006)
- EX-4.1 Specimen Stock Certificate (Filed With SEC on September 26, 2006)
- EX-1.1 Form of Underwriting Agreement (Filed With SEC on September 26, 2006)
- EXHIBIT 10.7 STOCK OPTION AGREEMENTS/CHARLES O'KEEFE (Filed With SEC on July 25, 2006)
- EXHIBIT 10.6 STOCK OPTION AGREEMENTS/JACK WEINTSTEIN (Filed With SEC on July 25, 2006)
- EXHIBIT 10.5 STOCK OPTION AGREEMENTS/HUBERT HUCKEL (Filed With SEC on July 25, 2006)
- EXHIBIT 10.4 STOCK OPTION AGREEMENTS/PATRICK J. MCENANY (Filed With SEC on July 25, 2006)
- Underwriting Agreement dated January 4, 2024, between Catalyst Pharmaceuticals, Inc. and BofA Securities, Inc. and Citigroup Global Markets, Inc., as representatives of the... (Filed With SEC on January 5, 2024)
- Underwriting Agreement, dated November 28, 2017, between Catalyst Pharmaceuticals, Inc. and Piper Jaffray & Co., as representative of the underwriters named in Schedule I thereto (Filed With SEC on November 28, 2017)
